NASDAQ
DICE Therapeutics, Inc. (DICE) has a free cash flow growth of -34.31% as of Friday, May 29, 2026. This represents a 171.19% decrease compared to its 12-month average of -12.65%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.